CCC Intelligent (CCCS) Exec Exercises Options and Sells Shares; Ownership Falls to 157,478
Rhea-AI Filing Summary
John Page Goodson, Executive Vice President, Chief Product and Technology Officer at CCC Intelligent Solutions Holdings Inc. (CCCS), exercised stock options and sold common stock on 09/17/2025. He acquired 150,000 shares by exercising options at an exercise price of $4.05 per share, and simultaneously sold 150,000 shares at a weighted-average price of $9.5911 per share. After these transactions, his reported beneficial ownership changed from 307,478 shares to 157,478 shares. The options exercised were originally granted in connection with the 2021 merger with Cypress Holdings, Inc., were performance-vested and deemed fully satisfied at issuance, and the exercised options have an expiration date of 09/24/2030.
Positive
- Acquired 150,000 shares by exercising options at a stated exercise price of $4.05 per share
- Sold 150,000 shares at a weighted-average price of $9.5911 per share (range $9.5550 to $9.6150) as disclosed
- Options were fully vested upon issuance in connection with the 2021 merger, per the filing
Negative
- Reported beneficial ownership decreased from 307,478 shares to 157,478 shares after the transactions
Insights
TL;DR: Insider exercised vested options and sold shares at a price materially above the exercise price, reducing his direct stake.
The filing shows a routine option exercise and sale by a senior executive: 150,000 shares were acquired via exercise at $4.05 and the same number of shares were sold at a weighted-average price of $9.5911. The net outcome reduced the reporting person’s beneficial holdings from 307,478 to 157,478 shares. The options trace to the 2021 merger and were fully vested when issued, with an expiration of 09/24/2030. This transaction is consistent with an executive monetizing vested equity while retaining a meaningful residual stake.
TL;DR: Transaction appears compliant and disclosed under Section 16; no regulatory concerns evident from the filing.
The Form 4 discloses the exercise of pre-existing, performance-vested options and contemporaneous sale of an equal number of shares. The filing includes an explanation of the weighted-average sale price range and confirms the options were fully vested upon issuance in connection with the 2021 merger. The form is signed by an attorney-in-fact and cites the applicable disclosure of sale prices. There are no statements of amendments or indications of Rule 10b5-1 reliance in this filing.